Cargando…

Influence of nonsteroidal anti-inflammatory drugs on aspirin’s antiplatelet effects and suggestion of the most suitable time for administration of both agents without resulting in interaction

BACKGROUND: Low-dose aspirin irreversibly inhibits platelet cyclooxygenase-1 (COX-1) and suppresses platelet aggregation. It is effective for secondary prevention of cardiovascular events. Because nonsteroidal anti-inflammatory drugs (NSAIDs) reversibly bind with COX-1, the antiplatelet effects of a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shibata, Kenta, Akagi, Yuuki, Nozawa, Naofumi, Shimomura, Hitoshi, Aoyama, Takao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345232/ https://www.ncbi.nlm.nih.gov/pubmed/28293429 http://dx.doi.org/10.1186/s40780-017-0078-7

Ejemplares similares

Erratum to: Influence of nonsteroidal anti-inflammatory drugs on aspirin’s antiplatelet effects and suggestion of the most suitable time for administration of both agents without resulting in interaction
por: Shibata, Kenta, et al.
Publicado: (2017)

Aspirin and antiplatelet treatments in cancer
por: Tao, Derrick L., et al.
Publicado: (2021)

Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy
por: Neubauer, Horst, et al.
Publicado: (2011)

Mapping the antiplatelet effects of clopidogrel and aspirin by modified thromboelastography
por: Hemlata,, et al.
Publicado: (2013)

Dissolvable polymeric microneedles loaded with aspirin for antiplatelet aggregation
por: Wang, Baorui, et al.
Publicado: (2023)

Does the timing of aspirin administration influence its antiplatelet effect – review of literature on chronotherapy
por: Miciak-Ławicka, Ewa, et al.
Publicado: (2018)

Effects of Antiplatelet and Nonsteroidal Anti-inflammatory Medications on Platelet-Rich Plasma: A Systematic Review
por: Frey, Christopher, et al.
Publicado: (2020)

Use of low-dose aspirin and non-aspirin nonsteroidal anti-inflammatory drugs and risk of glioma: a case–control study
por: Gaist, D, et al.
Publicado: (2013)

Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease
por: Pi, Lei, et al.
Publicado: (2018)

Aspirin desensitization in nonsteroidal anti-inflammatory exacerbated respiratory disease: The first prospective cohort in Chile
por: Siña, María Josefina, et al.
Publicado: (2023)

Celecoxib Does Not Attenuate the Antiplatelet Effects of Aspirin and Clopidogrel in Healthy Volunteers
por: Lee, Wonjae, et al.
Publicado: (2010)

Risk of recurrent stroke and antiplatelet choice in breakthrough stroke while on aspirin
por: Kim, Joon-Tae, et al.
Publicado: (2020)

Ticagrelor as an Alternative Antiplatelet Therapy in Cardiac Patients Non-Sensitive to Aspirin
por: Khan, Hamzah, et al.
Publicado: (2020)

Adherence to the preventive strategies for nonsteroidal anti-inflammatory drug- or low-dose aspirin-induced gastrointestinal injuries
por: Fujita, Tsuyoshi, et al.
Publicado: (2013)

The effect of aspirin and nonsteroidal anti-inflammatory drug use after diagnosis on survival of oesophageal cancer patients
por: van Staalduinen, Jente, et al.
Publicado: (2016)

The efficacy and safety of irsogladine maleate in nonsteroidal anti-inflammatory drug or aspirin-induced peptic ulcer and gastritis
por: Shim, Ki-Nam, et al.
Publicado: (2019)

Nonsteroidal anti-inflammatory drugs exacerbated respiratory disease – the role of aspirin desensitisation in patients with nasal polyposis
por: Jenerowicz, Dorota, et al.
Publicado: (2021)

Dual Antiplatelet Therapy with Clopidogrel and Aspirin Versus Aspirin Monotherapy in Patients Undergoing Coronary Artery Bypass Graft Surgery
por: Qu, Jianyu, et al.
Publicado: (2021)

Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient
por: Rossi, Giovanni, et al.
Publicado: (2020)

Nonsteroidal Anti-Inflammatory Drugs and Prostatic Diseases
por: Ishiguro, Hitoshi, et al.
Publicado: (2014)

Do Aspirin and Other Antiplatelet Drugs Reduce the Mortality in Critically Ill Patients?
por: Lösche, Wolfgang, et al.
Publicado: (2012)

Determinants of Reduced Antiplatelet Effect of Aspirin in Patients with Stable Coronary Artery Disease
por: Larsen, Sanne Bøjet, et al.
Publicado: (2015)

Effects of colchicine on platelet aggregation in patients on dual antiplatelet therapy with aspirin and clopidogrel
por: Cirillo, Plinio, et al.
Publicado: (2020)

Lower Antiplatelet Effect of Aspirin in Essential Thrombocythemia than in Coronary Artery Disease
por: Pedersen, Oliver Buchhave, et al.
Publicado: (2021)

Analysis of Gastrointestinal Prophylaxis in Patients Receiving Dual Antiplatelet Therapy with Aspirin and Clopidogrel
por: Morneau, Kathleen M., et al.
Publicado: (2014)

Interaction Between Low-Dose Aspirin and Nonsteroidal Anti-Inflammatory Drugs Can Compromise Aspirin’s Efficacy in Preventing Venous Thrombosis Following Total Joint Arthroplasty
por: Krauss, Eugene, et al.
Publicado: (2020)

Cost Effectiveness Associated with Helicobacter pylori Screening and Eradication in Patients Taking Nonsteroidal Anti-Inflammatory Drugs and/or Aspirin
por: Song, Hyun Jin, et al.
Publicado: (2013)

Systematic review: interactions between aspirin, and other nonsteroidal anti-inflammatory drugs, and polymorphisms in relation to colorectal cancer
por: Andersen, V, et al.
Publicado: (2014)

Initial Steps to Prevent Nonsteroidal Anti-Inflammatory Drug- or Aspirin-Induced Enteropathy: Long-Term Outcome Data
por: Lee, In Seok, et al.
Publicado: (2015)

Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel: Subanalysis of the CSPS.com Trial
por: Hoshino, Haruhiko, et al.
Publicado: (2021)

Nonsteroidal anti-inflammatory drugs, especially aspirin, are linked to lower risk and better survival of hepatocellular carcinoma: a meta-analysis
por: Tao, Yuquan, et al.
Publicado: (2018)

Association of nonsteroidal anti-inflammatory drugs and aspirin use and the risk of head and neck cancers: a meta-analysis of observational studies
por: Tang, Lanhua, et al.
Publicado: (2016)

The impact of selective serotonin receptor inhibitors on post-endoscopic sphincterotomy bleeding, alone or with concurrent aspirin or nonsteroidal anti-inflammatory drugs
por: Katsinelos, Panagiotis, et al.
Publicado: (2019)

Antiplatelet effects of aspirin are not affected by the soluble guanylate cyclase activator cinaciguat (BAY 58-2667)
por: Frey, Reiner, et al.
Publicado: (2011)

The dogma of aspirin: a critical review of evidence on the best monotherapy after dual antiplatelet therapy
por: Polo Friz, Hernan, et al.
Publicado: (2015)

Comparative evaluation of antiplatelet effect of lycopene with aspirin and the effect of their combination on platelet aggregation: An in vitro study
por: Sawardekar, Swapna B., et al.
Publicado: (2016)

Antiplatelet Effectivity between Aspirin with Honey on Cardiovascular Disease Based on Bleeding Time Taken on Mice
por: Martina, Sake Juli, et al.
Publicado: (2019)

Aspirin-free antiplatelet regimens after PCI: insights from the GLOBAL LEADERS trial and beyond
por: Wang, Rutao, et al.
Publicado: (2021)

Safety Comparison of Monotherapy Aspirin to Dual Antiplatelet Therapy Following Coronary Artery Bypass Surgery
por: Nei, Scott D., et al.
Publicado: (2022)

Antiplatelet Effects of Clopidogrel Vs Aspirin in Virologically Controlled HIV: A Randomized Controlled Trial
por: Marcantoni, Emanuela, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r0pat5rctvktfj58jd0q59g4en